Hoya Lens Australia and Designs for Vision (DFV) are joining forces to increase awareness of myopia management strategies and aid...
Read moreAustralian researchers have been at the fore of the largest genetic study of glaucoma that has identified 44 new genetic...
Read moreNova Eye Medical has announced an application to secure public funding for its iTrack ab-interno canaloplasty as a standalone minimally...
Read moreUnprecedented clinical interest in measuring axial length has fuelled a new partnership between the world’s largest multi-platform digital suite for...
Read moreA clinical trial is under way in Australia for a novel eye drop treatment for retinal vascular diseases that could...
Read moreThe parent companies of CooperVision and Essilor have announced a new joint venture to acquire a spectacle lens approved for...
Read moreAn Australian researcher has contributed to a new study demonstrating that lower carbohydrate consumption can potentially put type 2 diabetes...
Read moreAn ophthalmic pharmaceutical company has commenced two Phase 3 clinical studies to evaluate its eye drop candidate for presbyopia. Approximately...
Read moreSwiss drug giant Roche is poised to pursue regulatory clearance for its new faricimab antibody for diabetic macular edema (DME)...
Read moreDespite vehement opposition from ophthalmologists, the MBS Taskforce has forged ahead with plans to cut the rebate for intravitreal injections...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited